New perspectives in regenerative medicine and surgery: the bioactive composite therapies (BACTs)

Abstract

Regenerative medicine and surgery is a rapidly expanding branch of translational research in tissue engineering, cellular and molecular biology.To date, the methods to improve cell intake, survival, and isolation need to comply with a complex and still unclear regulatory frame, becoming everyday more restrictive and often limiting the effectiveness and outcome of the therapeutic choices. Thus, the authors developed a novel 360° regenerative strategy based on the synergic action of several new components called the bioactive composite therapies (BACTs) to improve grafted cells intake, and survival in total compliance with the legal and ethical limits of the current regulatory frame.The rationale at the origin of this new technology is based on the evidence that cells need supportive substrate to survive in vitro and this observation, applying the concept of translational medicine, is true also in vivo. Bioactive composite mixtures (BACMs) are tailor-made bioactive mixtures containing several bioactive components that support cells’ survival and induce a regenerative response in vivo by stimulating the recipient site to act as an in situ real bioreactor. Many different tissues have been used in the past for the isolation of cells, molecules, and growth factors, but the adipose tissue and its stromal vascular fraction (SVF) remains the most valuable, abundant, safe, and reliable source of regenerative components and particularly of adipose-derived stems cells (ADSCs). The role of plastic surgeons as the historical experts in all the most advanced techniques for harvesting, manipulating, and grafting adipose tissue is fundamental in this constant process of expansion of regenerative procedures. In this article, we analyze the main causes of cell death and the strategies for preventing it, and we present all the technical steps for preparing the main components of BACMs and the different mixing modalities to obtain the most efficient regenerative action on different clinical and pathological conditions. The second section of this work is dedicated to the logical and sequential evolution from simple bioactive composite grafts (BACGs) that distinguished our initial approach to regenerative medicine, to BACTs where many other fundamental technical steps are analyzed and integrated for supporting and enhancing the most efficient regenerative activity. Level of Evidence: Not gradable

Role for platelet rich plasma as an adjuvant therapy in wound healing and burns

“…We do note there are recent studies [45][46][47][48][49] which demonstrate some evidence for blood derivatives (PRP) being used in wound healing and severe burns. These studies did not fit our initial inclusion/search criteria but their results could provide early suggestion for some clinical benefit.…”

The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer

“…Their particular mesenchymal-like morphology, the expression profile of CD34 + , CD44 + , CD31 − and CD45 − , and their ability to produce osteoblasts, chondrocytes, myocytes and epithelial and neuronal cells allows ASCs to act as chemoattractant, angiogenic and prosurvival molecules [24]. The presence of ASCs gives to AT immunomodulatory, wound healing and regenerative properties [25,26]. All these functions are supported by additional mediators that live within the SVF and are released by ASC paracrine secretion, called ASC Exosomes.…”

Mesenchymal stem cell‐derived exosomes and skin photoaging: From basic research to practical application

“…Consequently, there is a need to develop cell‐free treatments that can replicate the beneficial effects of MSCs. It is now recognized that MSCs primarily exert their therapeutic effects through paracrine signaling, 13 and exosomes play a crucial role in mediating these effects 14 …”

“…It is now recognized that MSCs primarily exert their therapeutic effects through paracrine signaling, 13 and exosomes play a crucial role in mediating these effects. 14 Mesenchymal stem cells have a robust capacity to produce exosomes, and this production remains unaffected even when cells are immortalized to generate permanent cell lines. This ensures sustainable and reproducible exosome production from MSCs.…”